NCT03474640 2024-11-22Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Completed184 enrolled 20 charts